Literature DB >> 11882568

In search of cardiovascular candidate genes: interactions between phenotypes and genotypes.

Christian F Deschepper1, Isabelle Boutin-Ganache, Ahmad Zahabi, Zhibin Jiang.   

Abstract

Most cardiovascular traits of interest can be defined as "complex traits," with the first step in the identification of genetic factors affecting such traits being the detection of quantitative trait loci (QTLs). Animal models have proven particularly useful in this regard. However, only very few of the QTLs identified to date have led to the identification of candidate genes. We describe an example of our own work where the combination of anatomical and a biochemical intermediate phenotypes have led to the identification of the natriuretic peptide precursor A (Nppa) gene as a candidate gene for left ventricular hypertrophy (LVH). Combined with the power of comparative genetics, these strategies will continue to improve the chances of finding candidate genes for cardiovascular traits such as susceptibility to heart diseases, hypertension, and hypertension-induced end-organ damage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882568     DOI: 10.1161/hy0202.102787

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

Review 1.  Regression of left ventricular hypertrophy: are there preferred drugs?

Authors:  Joseph A Diamond; Robert A Phillips
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

Review 2.  Hereditary determinants of human hypertension: strategies in the setting of genetic complexity.

Authors:  Pei-an Betty Shih; Daniel T O'Connor
Journal:  Hypertension       Date:  2008-04-14       Impact factor: 10.190

Review 3.  Anti-hypertensive drugs and left ventricular hypertrophy: a clinical update.

Authors:  Alberto Milan; Mimma A Caserta; Eleonora Avenatti; Sara Abram; Franco Veglio
Journal:  Intern Emerg Med       Date:  2010-05-18       Impact factor: 3.397

4.  Quantitative trait mapping in Diversity Outbred mice identifies two genomic regions associated with heart size.

Authors:  John R Shorter; Wei Huang; Ju Youn Beak; Kunjie Hua; Daniel M Gatti; Fernando Pardo-Manuel de Villena; Daniel Pomp; Brian C Jensen
Journal:  Mamm Genome       Date:  2017-12-26       Impact factor: 2.957

Review 5.  Antihypertensive drugs and the heart.

Authors:  Joseph A Diamond; Robert A Phillips
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

6.  Association between transforming growth factor beta1 polymorphisms and left ventricle hypertrophy in essential hypertensive subjects.

Authors:  Hai-Ying Xu; Xu-Wei Hou; Li-Fang Wang; Ning-Fu Wang; Jian Xu
Journal:  Mol Cell Biochem       Date:  2009-08-29       Impact factor: 3.396

7.  Rapamycin attenuates pathological hypertrophy caused by an absence of trabecular formation.

Authors:  Nicole D Fleming; Leigh A Samsa; David Hassel; Li Qian; Jiandong Liu
Journal:  Sci Rep       Date:  2018-06-05       Impact factor: 4.379

8.  MicroRNA-29a attenuates angiotensin-II induced-left ventricular remodeling by inhibiting collagen, TGF-β and SMAD2/3 expression.

Authors:  Si-Jin Zhang; Cui-Juan Yun; Jie Liu; Si-Yu Yao; Yao Li; Miao Wang; Chi Wang; Yong-Yi Bai; Hao Xue
Journal:  J Geriatr Cardiol       Date:  2020-02       Impact factor: 3.327

9.  Dimethylarginine dimethylaminohydrolase1 is an organ-specific mediator of end organ damage in a murine model of hypertension.

Authors:  Karsten Sydow; Christine Schmitz; Eike-Christin von Leitner; Robin von Leitner; Anna Klinke; Dorothee Atzler; Christian Krebs; Hartwig Wieboldt; Heimo Ehmke; Edzard Schwedhelm; Thomas Meinertz; Stefan Blankenberg; Rainer H Böger; Tim Magnus; Stephan Baldus; Ulrich Wenzel
Journal:  PLoS One       Date:  2012-10-26       Impact factor: 3.240

10.  Rare Copy Number Variants Identified Suggest the Regulating Pathways in Hypertension-Related Left Ventricular Hypertrophy.

Authors:  Hoh Boon-Peng; Julia Ashazila Mat Jusoh; Christian R Marshall; Fadhlina Majid; Norlaila Danuri; Fashieha Basir; Bhooma Thiruvahindrapuram; Stephen W Scherer; Khalid Yusoff
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.